The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rotman, H. L.
Right arrow Articles by Long, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rotman, H. L.
Right arrow Articles by Long, C. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Malaria
The Journal of Immunology, 1998, 161: 1908-1912.
Copyright © 1998 by The American Association of Immunologists

Fc Receptors Are Not Required for Antibody-Mediated Protection Against Lethal Malaria Challenge in a Mouse Model1

Harris L. Rotman*, Thomas M. Daly*, Raphael Clynes{dagger} and Carole A. Long2,*

* Department of Microbiology and Immunology, Allegheny University of the Health Sciences, Philadelphia, PA 19129; and {dagger} Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10021

The mechanisms by which Abs mediate protection during blood-stage malaria infections is controversial, with some evidence pointing to the direct effect of Abs on parasite invasion and growth, while other studies suggest that Abs act in cooperation with monocytes to achieve parasite inhibition. To determine whether the effector phase of protection in vivo to the rodent parasite Plasmodium yoelii yoelii requires Fc receptor bearing cells, we passively transferred immune sera into FcR {gamma}-chain knockout mice. Inflammatory macrophages from these knockout mice were unable to mediate phagocytosis or Ab-dependent cell-mediated cytotoxicity (ADCC) through Fc{gamma}RI, Fc{gamma}RII, or Fc{gamma}RIII. Passive transfer of either P. y. yoelii hyperimmune sera or anti-GST-PYC2 sera directed to the major merozoite surface protein (MSP-1) of this parasite enabled both BALB/cByJ mice and FcR {gamma}-chain-deficient mice to resist lethal P. y. yoelii 17XL (Py17XL) challenge. mAb302, a protective IgG3 Ab, also passively protected both strains of mice. Most of these samples contain Ab isotypes that would not be able to protect mice if their protective effects required Ab-dependent cell-mediated cytotoxicity. These results establish that, in this infection, protection is directly mediated by Abs and does not require the participation of Fc receptors.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. M. Petritus and J. M. Burns Jr.
Suppression of Lethal Plasmodium yoelii Malaria following Protective Immunization Requires Antibody-, IL-4-, and IFN-{gamma}-Dependent Responses Induced by Vaccination and/or Challenge Infection
J. Immunol., January 1, 2008; 180(1): 444 - 453.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
P. Jeamwattanalert, Y. Mahakunkijcharoen, L. Kittigul, P. Mahannop, S. Pichyangkul, and C. Hirunpetcharat
Long-Lasting Protective Immune Response to the 19-Kilodalton Carboxy-Terminal Fragment of Plasmodium yoelii Merozoite Surface Protein 1 in Mice
Clin. Vaccine Immunol., April 1, 2007; 14(4): 342 - 347.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
D. L. Narum, S. A. Ogun, A. H. Batchelor, and A. A. Holder
Passive Immunization with a Multicomponent Vaccine against Conserved Domains of Apical Membrane Antigen 1 and 235-Kilodalton Rhoptry Proteins Protects Mice against Plasmodium yoelii Blood-Stage Challenge Infection.
Infect. Immun., October 1, 2006; 74(10): 5529 - 5536.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. E. M. Persson, C. T. Lee, K. Marsh, and J. G. Beeson
Development and Optimization of High-Throughput Methods To Measure Plasmodium falciparum-Specific Growth Inhibitory Antibodies.
J. Clin. Microbiol., May 1, 2006; 44(5): 1665 - 1673.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. Scorza, K. Grubb, P. Smooker, A. Rainczuk, D. Proll, and T. W. Spithill
Induction of Strain-Transcending Immunity against Plasmodium chabaudi adami Malaria with a Multiepitope DNA Vaccine
Infect. Immun., May 1, 2005; 73(5): 2974 - 2985.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. M. Burns Jr., P. R. Flaherty, P. Nanavati, and W. P. Weidanz
Protection against Plasmodium chabaudi Malaria Induced by Immunization with Apical Membrane Antigen 1 and Merozoite Surface Protein 1 in the Absence of Gamma Interferon or Interleukin-4
Infect. Immun., October 1, 2004; 72(10): 5605 - 5612.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. I. Spiridon, S. Guinn, and E. S. Vitetta
A Comparison of the in Vitro and in Vivo Activities of IgG and F(ab')2 Fragments of a Mixture of Three Monoclonal Anti-Her-2 Antibodies
Clin. Cancer Res., May 15, 2004; 10(10): 3542 - 3551.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. A. Okech, P. H. Corran, J. Todd, A. Joynson-Hicks, C. Uthaipibull, T. G. Egwang, A. A. Holder, and E. M. Riley
Fine Specificity of Serum Antibodies to Plasmodium falciparum Merozoite Surface Protein, PfMSP-119, Predicts Protection from Malaria Infection and High-Density Parasitemia
Infect. Immun., March 1, 2004; 72(3): 1557 - 1567.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. J. Pleass, S. A. Ogun, D. H. McGuinness, J. G. J. van de Winkel, A. A. Holder, and J. M. Woof
Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection
Blood, December 15, 2003; 102(13): 4424 - 4430.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Mold, B. Rodic-Polic, and T. W. Du Clos2
Protection from Streptococcus pneumoniae Infection by C-Reactive Protein and Natural Antibody Requires Complement But Not Fc{gamma} Receptors
J. Immunol., June 15, 2002; 168(12): 6375 - 6381.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. Ahlborg, I. T. Ling, W. Howard, A. A. Holder, and E. M. Riley
Protective Immune Responses to the 42-Kilodalton (kDa) Region of Plasmodium yoelii Merozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa Region
Infect. Immun., February 1, 2002; 70(2): 820 - 825.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Su and M. M. Stevenson
IL-12 Is Required for Antibody-Mediated Protective Immunity Against Blood-Stage Plasmodiumchabaudi AS Malaria Infection in Mice
J. Immunol., February 1, 2002; 168(3): 1348 - 1355.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. R. Taylor, E. Seixas, M. J. Walport, J. Langhorne, and M. Botto
Complement Contributes to Protective Immunity against Reinfection by Plasmodium chabaudi chabaudi Parasites
Infect. Immun., June 1, 2001; 69(6): 3853 - 3859.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yoneto, S. Waki, T. Takai, Y.-i. Tagawa, Y. Iwakura, J. Mizuguchi, H. Nariuchi, and T. Yoshimoto
A Critical Role of Fc Receptor-Mediated Antibody-Dependent Phagocytosis in the Host Resistance to Blood-Stage Plasmodium berghei XAT Infection
J. Immunol., May 15, 2001; 166(10): 6236 - 6241.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Vukovic, P. M. Hogarth, N. Barnes, D. C. Kaslow, and M. F. Good
Immunoglobulin G3 Antibodies Specific for the 19-Kilodalton Carboxyl-Terminal Fragment of Plasmodium yoelii Merozoite Surface Protein 1 Transfer Protection to Mice Deficient in Fc-gamma RI Receptors
Infect. Immun., May 1, 2000; 68(5): 3019 - 3022.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N. Ahlborg, I. T. Ling, A. A. Holder, and E. M. Riley
Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119
Infect. Immun., April 1, 2000; 68(4): 2102 - 2109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.